Bone status in patients with epilepsy: relationship to markers of bone remodeling
Patients with epilepsy and treated with antiepileptic drugs (AEDs) may develop metabolic bone disease, however, the exact pathogenesis of bone loss with AEDs is still unclear. Included were 75 adults with epilepsy (mean age: 31.90±5.62years; duration of treatment with AEDs: 10.57±3.55years) and 40 m...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00142/full |
id |
doaj-af08b30aa3024c5a96e510014ea2cb70 |
---|---|
record_format |
Article |
spelling |
doaj-af08b30aa3024c5a96e510014ea2cb702020-11-24T22:48:05ZengFrontiers Media S.A.Frontiers in Neurology1664-22952014-08-01510.3389/fneur.2014.00142103586Bone status in patients with epilepsy: relationship to markers of bone remodelingSherifa Ahmed Hamed0Ehab eMansour1Ahmed Hamdy Youssef2Mohammed eAbd ElHameed3Eman eMohamad4Assiut University HospitalAssiut University HospitalAssiut University HospitalAssiut University HospitalAssiut University HospitalPatients with epilepsy and treated with antiepileptic drugs (AEDs) may develop metabolic bone disease, however, the exact pathogenesis of bone loss with AEDs is still unclear. Included were 75 adults with epilepsy (mean age: 31.90±5.62years; duration of treatment with AEDs: 10.57±3.55years) and 40 matched healthy controls. Bone mineral content (BMC) and densities (BMD) of the femoral neck and lumbar spine were measured using dual energy X-ray absorptiometry (DEXA). Blood samples were analyzed for calcium, magnesium, phosphate, alkaline phosphatase (ALP), 25-hydroxy vitamin D (25OHD), soluble receptor activator of nuclear factor kB ligand (sRANKL), osteoprotegerin (OPG) and OPG/RANKL ratio (markers of bone remodeling). Compared to controls, patients had lower BMD, BMC, Z-score and T-score at the femoral neck and lumbar spine (all p<0.001). 72% and 29.33% of patients had osteoporosis of the lumbar spine and femoral neck. Patients had significantly lower serum calcium, 25(OH)D and OPG and higher ALP, sRANKL levels and sRANKL/OPG (all p<0.001). 52% of patients had hypocalcemia, 93% had hypovitaminosis D, 31% had high levels of sRANKL and 49% had low levels of OPG. No differences were identified between DEXA and laboratory results in relation to the type, dose or serum levels of AEDs. BMD at the femoral neck and lumbar spine were found to be correlated with the duration of illness (p=0.043; p=0.010), duration of treatment with AEDs (p<0.001; p=0.012) and serum levels of 25(OH)D (p<0.042; p=0.010), sRANKLs (p=0.005; p=0.01) and OPG (p<0.006; p<0.01). In linear regression analysis and after adjusting for gender, age, weight, duration and number of AEDs, we observed an association between BMD, 25(OH)D (p=0.04) and sRANKL (p=0.03) concentrations. We conclude that AEDs may compromise bone health through disturbance of mineral metabolism and acceleration of bone turnover mechanisms.http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00142/fullOsteoprotegerinantiepileptic drugsbone mineral density25OHDreceptor activator of nuclear factor-kappa B ligand |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sherifa Ahmed Hamed Ehab eMansour Ahmed Hamdy Youssef Mohammed eAbd ElHameed Eman eMohamad |
spellingShingle |
Sherifa Ahmed Hamed Ehab eMansour Ahmed Hamdy Youssef Mohammed eAbd ElHameed Eman eMohamad Bone status in patients with epilepsy: relationship to markers of bone remodeling Frontiers in Neurology Osteoprotegerin antiepileptic drugs bone mineral density 25OHD receptor activator of nuclear factor-kappa B ligand |
author_facet |
Sherifa Ahmed Hamed Ehab eMansour Ahmed Hamdy Youssef Mohammed eAbd ElHameed Eman eMohamad |
author_sort |
Sherifa Ahmed Hamed |
title |
Bone status in patients with epilepsy: relationship to markers of bone remodeling |
title_short |
Bone status in patients with epilepsy: relationship to markers of bone remodeling |
title_full |
Bone status in patients with epilepsy: relationship to markers of bone remodeling |
title_fullStr |
Bone status in patients with epilepsy: relationship to markers of bone remodeling |
title_full_unstemmed |
Bone status in patients with epilepsy: relationship to markers of bone remodeling |
title_sort |
bone status in patients with epilepsy: relationship to markers of bone remodeling |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neurology |
issn |
1664-2295 |
publishDate |
2014-08-01 |
description |
Patients with epilepsy and treated with antiepileptic drugs (AEDs) may develop metabolic bone disease, however, the exact pathogenesis of bone loss with AEDs is still unclear. Included were 75 adults with epilepsy (mean age: 31.90±5.62years; duration of treatment with AEDs: 10.57±3.55years) and 40 matched healthy controls. Bone mineral content (BMC) and densities (BMD) of the femoral neck and lumbar spine were measured using dual energy X-ray absorptiometry (DEXA). Blood samples were analyzed for calcium, magnesium, phosphate, alkaline phosphatase (ALP), 25-hydroxy vitamin D (25OHD), soluble receptor activator of nuclear factor kB ligand (sRANKL), osteoprotegerin (OPG) and OPG/RANKL ratio (markers of bone remodeling). Compared to controls, patients had lower BMD, BMC, Z-score and T-score at the femoral neck and lumbar spine (all p<0.001). 72% and 29.33% of patients had osteoporosis of the lumbar spine and femoral neck. Patients had significantly lower serum calcium, 25(OH)D and OPG and higher ALP, sRANKL levels and sRANKL/OPG (all p<0.001). 52% of patients had hypocalcemia, 93% had hypovitaminosis D, 31% had high levels of sRANKL and 49% had low levels of OPG. No differences were identified between DEXA and laboratory results in relation to the type, dose or serum levels of AEDs. BMD at the femoral neck and lumbar spine were found to be correlated with the duration of illness (p=0.043; p=0.010), duration of treatment with AEDs (p<0.001; p=0.012) and serum levels of 25(OH)D (p<0.042; p=0.010), sRANKLs (p=0.005; p=0.01) and OPG (p<0.006; p<0.01). In linear regression analysis and after adjusting for gender, age, weight, duration and number of AEDs, we observed an association between BMD, 25(OH)D (p=0.04) and sRANKL (p=0.03) concentrations. We conclude that AEDs may compromise bone health through disturbance of mineral metabolism and acceleration of bone turnover mechanisms. |
topic |
Osteoprotegerin antiepileptic drugs bone mineral density 25OHD receptor activator of nuclear factor-kappa B ligand |
url |
http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00142/full |
work_keys_str_mv |
AT sherifaahmedhamed bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling AT ehabemansour bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling AT ahmedhamdyyoussef bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling AT mohammedeabdelhameed bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling AT emanemohamad bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling |
_version_ |
1725679753189392384 |